Skip to main navigation Skip to search Skip to main content

Kawasaki disease: An update on diagnosis and treatment

  • Ho Chang Kuo
  • , Kuender D. Yang
  • , Wei Chiao Chang
  • , Luo Ping Ger
  • , Kai Sheng Hsieh*
  • *Corresponding author for this work
  • Chang Gung Memorial Hospital
  • Show-Chwan Memorial Hospital Taiwan
  • Kaohsiung Medical University
  • Veterans General Hospital-Kaohsiung Taiwan
  • National Yang Ming Chiao Tung University

Research output: Contribution to journalReview articlepeer-review

122 Scopus citations

Abstract

Kawasaki disease (KD) is an acute multi-system vasculitis syndrome of unknown etiology occurring mostly in infants and children younger than 5 years of age. In developed countries, it is the leading cause of acquired heart disease in children. However, KD remains a mysterious disease. Some viruses potentially causing the condition have been isolated, but the results have not been able to be reproduced. This article reviews and summarizes different aspects of KD and provides updated information on diagnosis and treatment. The supplementary criteria for incomplete presentation of KD patients suggested by the American Heart Association, treatment (including tumor necrosis factor-alpha antagonist, methylprednisolone pulse therapy, statins, plasma exchange, and cytotoxic agents) for those with intravenous immunoglobulin treatment failure, and other experiences are also included in this review.

Original languageEnglish
Pages (from-to)4-11
Number of pages8
JournalPediatrics and Neonatology
Volume53
Issue number1
DOIs
StatePublished - 02 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • IVIG
  • Kawasaki disease
  • coronary artery lesion

Fingerprint

Dive into the research topics of 'Kawasaki disease: An update on diagnosis and treatment'. Together they form a unique fingerprint.

Cite this